DRKS00027897招募中不适用
Expression of potential biomarker in pancreatic cancer
niklinik Köln0 个研究点目标入组 80 人开始时间: 2022年9月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •= 18 years, male or female
- •- Patients with a confirmed diagnosis of pancreatic cancer (ICD-10, C25)
- •- Healthy controls: no known malignancy, no permanent medication, normal weight (BMI 18.5 - 24.9).
- •- Present declaration of consent
排除标准
- •- Non-compliance with inclusion criteria
- •- other malignancy
- •- known autoimmune disease
- •- Indications that the subject is unlikely to comply with the test plan (e.g. lack of willingness to cooperate)
研究者
相似试验
招募中
不适用
Research of serum biomarker for pancreatic or bile duct cancers using peptide analysispancreatic cancer, bile duct cancerJPRN-UMIN000040276niverstiy of Toyama200
未知
不适用
Genomic biomarker research for advanced pancreatic cancer and neuroendocrine tumor.JPRN-UMIN000022960Chiba Cancer Center230
尚未招募
Unknown
Elucidation of new molecular mechanism of pancreatic cancer development by subgingival plaque microbiome analysispancreatic cancerJPRN-UMIN000052739Shimane University90
招募中
不适用
Biomarker discovery in pancreatobiliary cancer, solid pseudopapillary neoplasm and neuroendocrine tumor, and clinical validation of the candidate biomarkersDiseases of the digestive systemKCT0000436Yonsei University Health System, Severance Hospital40
招募中
1 期
Development of a diagnostic method for pancreatic cancer using 13C glucosePancreatic cancer, benign pancreatic diseases, or other gastroenterological cancersPancreatic cancerJPRN-jRCTs051210205Tobimatsu Kazutoshi60